Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.

Company Growth (employees)
Cambridge, US
Size (employees)
11 (est)-8%
Gen9 was founded in 2009 and is headquartered in Cambridge, US

Gen9 Office Locations

Gen9 has an office in Cambridge

Gen9 Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$50.1 m

Latest funding size

$25 m

Time since last funding

over 3 years


Gen9's latest funding round in July 2014 was reported to be $25 m. In total, Gen9 has raised $50.1 m

Gen9's Web-traffic and Trends

Gen9 Online and Social Media Presence

Gen9 Company Life and Culture

You may also be interested in